Funded Grants

PI Name PI Organization Sort ascending Title Grant Number Program Official
Snyder, Michael P.

Stanford University
United States

Precancer Atlas of Familial Adenomatous Polyposis 3U2CCA233311-01S1 Richard Mazurchuk, Ph.D.
Counter, Christopher M

Duke University
United States

Adapting K-MDS to detect KRAS-mutant ctDNA 5R21CA257816-02
Crew, Katherine D

Columbia University Health Sciences
United States

Multicenter trial of decision support for breast cancer chemoprevention 3R01CA226060-05S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Li, Bing

University Of Iowa
United States

E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function 5R01CA180986-10 Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S2 Guillermo Marquez, Ph.D.
Dhakal, Soma

Virginia Commonwealth University
United States

Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers 5R61CA278445-02 Christos Patriotis, Ph.D., M.Sc.
Singh, Shivendra

University Of Pittsburgh At Pittsburgh
United States

Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer 5R01CA225716-05 Howard L. Parnes, M.D.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women 5R01CA260628-03 Christos Patriotis, Ph.D., M.Sc.
Temprosa, Marinella

George Washington University
United States

22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center 2U01DK048489-28 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cohn, Barbara A

Public Health Institute
United States

Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer 5R01CA264519-03 Howard L. Parnes, M.D.